The successful development and commercialization of Cell and Gene Therapy products has provided hope for patients with urgent medical needs and opened a door for a new era of modern medicine.

However, the manufacturing of products is very complex and they have to be released in a short timeframe. These are high-value products, available in limited quantities that should be controlled employing a complex set of tests in order to ensure identity, safety, and potency.

The current microbiological compendial methods like sterility and mycoplasma testing are not adapted to these products.

During this tutorial industry experts will address:

• QC testing strategies to improve manufacturing turnaround time
• bioMérieux microbiology testing solutions for increased operational efficiency and improved patient safety and
• How to make rapid testing mainstream for ATMPs through a Q&A session

To find out more click the green "Request Information" button below or watch the webinar here